Kathleen McGroddy-Goetz - Jun 8, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ David B. Berger, Attorney-in-Fact for Kathleen McGroddy-Goetz
Stock symbol
TNDM
Transactions as of
Jun 8, 2021
Transactions value $
$0
Form type
4
Date filed
6/10/2021, 04:56 PM
Previous filing
May 20, 2021
Next filing
Mar 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1.22K $0.00 1.22K Jun 8, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -1.22K -33.32% $0.00 2.44K Jun 8, 2021 Common Stock 1.22K Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.
F3 This RSU award was granted on June 8, 2020. 33% of the RSU vested on June 8, 2021 and the remaining 67% will vest annually over the next two years.
F4 The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.